In cancer, the aberrant activation of the PI3K-AKT pathway not only promotes cell survival and growth but also enhances the antioxidant defense mechanisms, contributing to tumor progression and resistance to therapies that induce oxidative stress, such as chemotherapy and radiation. The gene discussed is AKT1; the disease is cancer.